248 related articles for article (PubMed ID: 27875780)
1. VP1 residues around the five-fold axis of enterovirus A71 mediate heparan sulfate interaction.
Tan CW; Sam IC; Lee VS; Wong HV; Chan YF
Virology; 2017 Jan; 501():79-87. PubMed ID: 27875780
[TBL] [Abstract][Full Text] [Related]
2. 3,4-Dicaffeoylquinic Acid from the Medicinal Plant
Hsieh CF; Chen YL; Lin GH; Chan YF; Hsieh PW; Horng JT
J Virol; 2022 Apr; 96(7):e0054221. PubMed ID: 35319229
[TBL] [Abstract][Full Text] [Related]
3. Rosmarinic acid exhibits broad anti-enterovirus A71 activity by inhibiting the interaction between the five-fold axis of capsid VP1 and cognate sulfated receptors.
Hsieh CF; Jheng JR; Lin GH; Chen YL; Ho JY; Liu CJ; Hsu KY; Chen YS; Chan YF; Yu HM; Hsieh PW; Chern JH; Horng JT
Emerg Microbes Infect; 2020 Dec; 9(1):1194-1205. PubMed ID: 32397909
[TBL] [Abstract][Full Text] [Related]
4. Electrostatic interactions at the five-fold axis alter heparin-binding phenotype and drive enterovirus A71 virulence in mice.
Tee HK; Tan CW; Yogarajah T; Lee MHP; Chai HJ; Hanapi NA; Yusof SR; Ong KC; Lee VS; Sam IC; Chan YF
PLoS Pathog; 2019 Nov; 15(11):e1007863. PubMed ID: 31730673
[TBL] [Abstract][Full Text] [Related]
5. The Suramin Derivative NF449 Interacts with the 5-fold Vertex of the Enterovirus A71 Capsid to Prevent Virus Attachment to PSGL-1 and Heparan Sulfate.
Nishimura Y; McLaughlin NP; Pan J; Goldstein S; Hafenstein S; Shimizu H; Winkler JD; Bergelson JM
PLoS Pathog; 2015 Oct; 11(10):e1005184. PubMed ID: 26430888
[TBL] [Abstract][Full Text] [Related]
6. A Selective Bottleneck Shapes the Evolutionary Mutant Spectra of Enterovirus A71 during Viral Dissemination in Humans.
Huang SW; Huang YH; Tsai HP; Kuo PH; Wang SM; Liu CC; Wang JR
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931688
[TBL] [Abstract][Full Text] [Related]
7. Cellular receptors for enterovirus A71.
Kobayashi K; Koike S
J Biomed Sci; 2020 Jan; 27(1):23. PubMed ID: 31924205
[TBL] [Abstract][Full Text] [Related]
8. Enterovirus A71 Containing Codon-Deoptimized VP1 and High-Fidelity Polymerase as Next-Generation Vaccine Candidate.
Tsai YH; Huang SW; Hsieh WS; Cheng CK; Chang CF; Wang YF; Wang JR
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996087
[TBL] [Abstract][Full Text] [Related]
9. Variant enterovirus A71 found in immune-suppressed patient binds to heparan sulfate and exhibits neurotropism in B-cell-depleted mice.
Weng KF; Tee HK; Tseligka ED; Cagno V; Mathez G; Rosset S; Nagamine CM; Sarnow P; Kirkegaard K; Tapparel C
Cell Rep; 2023 Apr; 42(4):112389. PubMed ID: 37058406
[TBL] [Abstract][Full Text] [Related]
10. Genetic evolution of Human Enterovirus A71 subgenotype C4 in Shenzhen, China, 1998-2013.
He Y; Zou L; Chong MKC; Men R; Xu W; Yang H; Yao X; Chen L; Xian H; Zhang H; Luo M; Cheng J; Ma H; Feng Q; Huang Y; Wang Y; Yeoh EK; Zee BC; Zhou Y; He ML; Wang MH
J Infect; 2016 Jun; 72(6):731-737. PubMed ID: 27038503
[TBL] [Abstract][Full Text] [Related]
11. Human Dendritic Cells Transmit Enterovirus A71 via Heparan Sulfates to Target Cells Independent of Viral Replication.
Helgers LC; Bhoekhan MS; Pajkrt D; Wolthers KC; Geijtenbeek TBH; Sridhar A
Microbiol Spectr; 2022 Dec; 10(6):e0282222. PubMed ID: 36222686
[TBL] [Abstract][Full Text] [Related]
12. Enterovirus A71 VP1 Variation A289T Decreases the Central Nervous System Infectivity via Attenuation of Interactions between VP1 and Vimentin In Vitro and In Vivo.
Zhu H; Cao Y; Su W; Huang S; Lu W; Zhou Y; Gao J; Zhao W; Zhang B; Wu X
Viruses; 2019 May; 11(5):. PubMed ID: 31121933
[TBL] [Abstract][Full Text] [Related]
13. Viral determinants that drive Enterovirus-A71 fitness and virulence.
Ang PY; Chong CWH; Alonso S
Emerg Microbes Infect; 2021 Dec; 10(1):713-724. PubMed ID: 33745413
[TBL] [Abstract][Full Text] [Related]
14. Viral engagement with host receptors blocked by a novel class of tryptophan dendrimers that targets the 5-fold-axis of the enterovirus-A71 capsid.
Sun L; Lee H; Thibaut HJ; Lanko K; Rivero-Buceta E; Bator C; Martinez-Gualda B; Dallmeier K; Delang L; Leyssen P; Gago F; San-Félix A; Hafenstein S; Mirabelli C; Neyts J
PLoS Pathog; 2019 May; 15(5):e1007760. PubMed ID: 31071193
[TBL] [Abstract][Full Text] [Related]
15. Development of a full-length cDNA-derived enterovirus A71 vaccine candidate using reverse genetics technology.
Yang YT; Chow YH; Hsiao KN; Hu KC; Chiang JR; Wu SC; Chong P; Liu CC
Antiviral Res; 2016 Aug; 132():225-32. PubMed ID: 27387826
[TBL] [Abstract][Full Text] [Related]
16. Characterization of three small molecule inhibitors of enterovirus 71 identified from screening of a library of natural products.
Li G; Gao Q; Yuan S; Wang L; Altmeyer R; Lan K; Yin F; Zou G
Antiviral Res; 2017 Jul; 143():85-96. PubMed ID: 28412182
[TBL] [Abstract][Full Text] [Related]
17. Mapping Enterovirus A71 Antigenic Determinants from Viral Evolution.
Huang SW; Tai CH; Fonville JM; Lin CH; Wang SM; Liu CC; Su IJ; Smith DJ; Wang JR
J Virol; 2015 Nov; 89(22):11500-6. PubMed ID: 26339057
[TBL] [Abstract][Full Text] [Related]
18. Hand, foot and mouth disease and herpangina caused by enterovirus A71 infections: a review of enterovirus A71 molecular epidemiology, pathogenesis, and current vaccine development.
Chang YK; Chen KH; Chen KT
Rev Inst Med Trop Sao Paulo; 2018 Nov; 60():e70. PubMed ID: 30427405
[TBL] [Abstract][Full Text] [Related]
19. Adaptation and Virulence of Enterovirus-A71.
Kobayashi K; Koike S
Viruses; 2021 Aug; 13(8):. PubMed ID: 34452525
[TBL] [Abstract][Full Text] [Related]
20. Amino acid variation at VP1-145 of enterovirus A71 determines the viral infectivity and receptor usage in a primary human intestinal model.
Aknouch I; García-Rodríguez I; Giugliano FP; Calitz C; Koen G; van Eijk H; Johannessson N; Rebers S; Brouwer L; Muncan V; Stittelaar KJ; Pajkrt D; Wolthers KC; Sridhar A
Front Microbiol; 2023; 14():1045587. PubMed ID: 37138595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
